Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-13-046192
Filing Date
2013-12-13
Accepted
2013-12-13 18:07:47
Documents
1
Period of Report
2013-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 15177
  Complete submission text file 0001140361-13-046192.txt   16505
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 131277337